Filing Details
- Accession Number:
- 0001562180-23-000408
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-13 16:19:31
- Reporting Period:
- 2023-01-11
- Accepted Time:
- 2023-01-13 16:19:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1944069 | A Richard Colvin | C/O Bluebird Bio, Inc 455 Grand Union Boulevard Somerville MA 02145 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-01-11 | 557 | $7.80 | 74,231 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- The range in prices for the transaction reported on this line was $7.61 to $7.93. The average weighted price was $7.8043. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.